ACO Name and Location

PQN – Central Texas, LLC
950 N Glebe Rd Suite 700
Arlington, VA 22203

ACO Primary Contact

Michael Richmond
Phone: 571-366-8850
Email: mrichmond@priviahealth.com

Organizational Information

ACO Participants:

ACO Participants ACO Participant in Joint Venture
Texas Health Care, P.L.L.C. N
Kare Family Clinic N

ACO Governing Body:

Member First Name Member Last Name Member Title/Position * Member’s Voting Power – Expressed as a percentage Membership Type ACO Participant TIN Legal Business Name/DBA, if Applicable ACO Participant DBA, if applicable
John Lawley Director 7.1428%      
David Stroman, M.D. Director 7.1428% ACO Participant Representative Texas Health Care P.L.L.C.  
Travis Crudup, M.D. Director 7.1428% ACO Participant Representative Texas Health Care P.L.L.C.  
Jason Ledbetter, M.D. Director 7.1428% ACO Participant Representative Texas Health Care P.L.L.C.  
Lynne Tilkin, D.O. Director 7.1428% ACO Participant Representative Texas Health Care P.L.L.C.  
Michelle Torres, M.D. Director 7.1428% ACO Participant Representative Texas Health Care P.L.L.C.  
Ben Marcum, M.D. Director 7.1428% ACO Participant Representative Texas Health Care P.L.L.C.  
Jim Bothwell, M.D. Director 7.1428% ACO Participant Representative Texas Health Care P.L.L.C.  
James Harvey, M.D. Director 7.1428% ACO Participant Representative Texas Health Care P.L.L.C.  
Amber Lesley, M.D. Director 7.1428% ACO Participant Representative Texas Health Care P.L.L.C.  
David Brigati, M.D. Director 7.1428% ACO Participant Representative Texas Health Care P.L.L.C.  
Bartley Bryt, M.D. Director 7.1428%   N/A  
Eric Beyers Director 7.1428%   N/A  
Don Dearmore Director 7.1428% Medicare Beneficiary Representative N/A  

* – Due to rounding, the members voting power total may not equal 100%

Key ACO Clinical and Administrative Leadership:

  • ACO Executive: John Lawley
  • Medical Director: Raymond Blair, M.D.
  • Compliance Officer: Stephanie Clark
  • Quality Assurance/Improvement Officer: Raymond Blair, M.D.

Associated Committees and Committee Leadership:

Committee Name Committee Leader Name & Position
 N/A N/A

Types of ACO participants, or combinations of participants, that formed the ACO:

  • ACO professionals in a group practice arrangement

 

Shared Savings and Losses

Amount of Shared Savings/Losses

  • Third Agreement Period
    • Performance Year 2024: $7,079,560.82
    • Performance Year 2023: $6,380,239.56
    • Performance Year 2022: $4,409,482
  • Second Agreement Period
    • Performance Year 2021: $2,740,199.17
    • Performance Year 2020: $0
    • Performance Year 2019: $1,407,570.88
    • Performance Year 2018: $2,232,723

Shared Savings Distribution

  • Third Agreement Period
    • Performance Year 2024
      • Proportion invested in infrastructure: 41.0%
      • Proportion invested in redesigned care processes/resources: 10.1%
      • Proportion of distribution to ACO participants: 48.9%
    • Performance Year 2023
      • Proportion invested in infrastructure: 37%
      • Proportion invested in redesigned care processes/resources: 13%
      • Proportion of distribution to ACO participants: 50%
    • Performance Year 2022
      • Proportion invested in infrastructure: 44%
      • Proportion invested in redesigned care processes/resources: 15%
      • Proportion of distribution to ACO participants: 41%
  • Second Agreement Period
    • Performance Year 2021
      • Proportion invested in infrastructure: 30%
      • Proportion invested in redesigned care processes/resources: 25%
      • Proportion of distribution to ACO participants: 45%
    • Performance Year 2020
      • Proportion invested in infrastructure: n/a
      • Proportion invested in redesigned care processes/resources: n/a
      • Proportion of distribution to ACO participants: n/a
    • Performance Year 2019
      • Proportion invested in infrastructure: 30%
      • Proportion invested in redesigned care processes/resources: 25%
      • Proportion of distribution to ACO participants: 45%
    • Performance Year 2018
      • Proportion invested in infrastructure: 30%
      • Proportion invested in redesigned care processes/resources: 25%
      • Proportion of distribution to ACO participants: 45%

Quality Performance Results

2024 Quality Performance Results:

Quality Performance Results are based on CMS Web Interface Measure Set

Measure # Measure Name Collection Type REPORTED PERFORMANCE RATE CURRENT YEAR MEAN PERFORMANCE RATE (SSP ACO’S)
Measure # 001 Diabetes: Hemoglobin A1c (HbA1c) Poor Control (>9%) CMS Web Interface 7.60 9.44
Measure # 134 Preventative Care and Screening: Screening for Depression and Follow-up Plan CMS Web Interface 87.94 81.46
Measure # 236 Controlling High Blood Pressure CMS Web Interface 85.94 79.49
Measure # 318 Falls: Screening for Future Fall Risk CMS Web Interface 90.94 88.99
Measure # 110 Preventative Care and Screening: Influenza Immunization CMS Web Interface 59.39 68.60
Measure # 226 Preventative Care and Screening: Tobacco Use: Screening and Cessation Intervention CMS Web Interface 81.82 79.98
Measure # 113 Colorectal Cancer Screening CMS Web Interface 85.08 77.81
Measure # 112 Breast Cancer Screening CMS Web Interface 82.65 80.93
Measure # 438 Statin Therapy for the Prevention and Treatment of Cardiovascular Disease CMS Web Interface 84.71 86.50
Measure # 370 Depression Remission at Twelve Months CMS Web Interface 24.49 17.35
Measure # 321 CAHPS for MIPS CMS Web Interface 7.92 6.67
Measure # 479 Hospital-Wide, 30-Day, All-Cause Unplanned Readmission (HWR) Rate for MIPS Groups CMS Web Interface 0.1539 0.1517
Measure # 484 Clinician and Clinician Group Risk-standardized Hospital Admission Rates for Patients with Multiple Chronic Conditions CMS Web Interface 33.97 37.00
CAHPS-1 Getting Timely Care, Appointments, and Information CAHPS for MIPS Survey 87.88 83.70
CAHPS-2 How Well Providers Communicate CAHPS for MIPS Survey 94.93 93.96
CAHPS-3 Patient’s Rating of Provider CAHPS for MIPS Survey 93.50 92.43
CAHPS-4 Access to Specialists CAHPS for MIPS Survey 77.55 75.76
CAHPS-5 Health Promotion and Education CAHPS for MIPS Survey 67.07 65.48
CAHPS-6 Shared Decision Making CAHPS for MIPS Survey 61.59 62.31
CAHPS-7 Health Status and Functional Status CAHPS for MIPS Survey 77.81 74.14
CAHPS-8 Care Coordination CAHPS for MIPS Survey 86.45 85.89
CAHPS-9 Courteous and Helpful Office Staff CAHPS for MIPS Survey 93.41 92.89
CAHPS-11 Stewardship of Patient Resources CAHPS for MIPS Survey 25.33 26.98
  • *For Diabetes: Hemoglobin A1c (HbA1c) Poor Control (>9%) [Quality ID #001], Hospital-Wide, 30-Day, All-Cause Unplanned Readmission (HWR) Rate for MIPS Eligible Clinician Groups [Measure #479], and Clinician and Clinician Group Risk-standardized Hospital Admission Rates for Patients with Multiple Chronic Conditions (MCC) [Measure #484], a lower performance rate indicates better measure performance.
  • *For Clinician and Clinician Group Risk-standardized Hospital Admission Rates for Patients with Multiple Chronic Conditions (MCC) [Measure #484], patients are excluded if they were attributed to Qualifying Alternative Payment Model (APM) Participants (QPs). Most providers participating in Track E and ENHANCED track ACOs are QPs, and so performance rates for Track E and ENHANCED track ACOs may not be representative of the care provided by these ACOs’ providers overall. Additionally, many of these ACOs do not have a performance rate calculated due to not meeting the minimum of 18 beneficiaries attributed to non-QP providers.

For Previous Years’ Financial and Quality Performance Results, Please Visit data.cms.gov